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Abstract
The mycotoxin deoxynivalenol (DON), one of the most common food contaminants, primarily targets the gastrointestinal
tract to affect animal and human health. This study was conducted to examine the protective function of glutamic acid on
intestinal injury and oxidative stress caused by DON in piglets. Twenty-eight piglets were assigned randomly into 4 dietary
treatments (7 pigs/treatment): 1) uncontaminated control diet (NC), 2) NC+DON at 4 mg/kg (DON), 3) NC+2% glutamic acid
(GLU), and 4) NC+2% glutamic acid + DON at 4 mg/kg (DG). At day 15, 30 and 37, blood samples were collected to
determine serum concentrations of CAT (catalase), T-AOC (total antioxidant capacity), H2O2 (hydrogen peroxide), NO (nitric
oxide), MDA (maleic dialdehyde), DAO (diamine oxidase) and D-lactate. Intestinal morphology, and the activation of Akt/
mTOR/4EBP1 signal pathway, as well as the concentrations of H2O2, MDA, and DAO in kidney, liver and small intestine, were
analyzed at day 37. Results showed that DON significantly (P,0.05) induced oxidative stress in piglets, while this stress was
remarkably reduced with glutamic acid supplementation according to the change of oxidative parameters in blood and
tissues. Meanwhile, DON caused obvious intestinal injury from microscopic observations and permeability indicators, which
was alleviated by glutamic acid supplementation. Moreover, the inhibition of DON on Akt/mTOR/4EBP1 signal pathway was
reduced by glutamic acid supplementation. Collectively, these data suggest that glutamic acid may be a useful nutritional
regulator for DON-induced damage manifested as oxidative stress, intestinal injury and signaling inhibition.
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Introduction
Deoxynivalenol (DON) is the most pervasive mycotoxin, which
are found worldwide in various foods and animal feeds [1–3]. The
initial adverse effects observed after DON exposure are reduced
feed intake, emesis, diarrhea, and anorexia [4]. DON becomes a
serious problem in animal production worldwide, especially in
pigs, because of its adverse effects on brain, liver, kidney, and
mostly gastrointestinal tract [5–10]. These adverse effects include
the inhibitions of DNA, RNA and protein synthesis, and lesions in
the gastrointestinal tract, affecting its barrier function, as well as
modulation of the anti-oxidative system [9,11–14]. Although
DON causes a big economical loss to swine production, little has
been done to investigate the nutritional strategy that may be useful
in protecting pigs from the damage caused by consuming DON in
contaminated diets.
Glutamic acid, a functional amino acid, plays various crucial
roles in the intestinal tract, including (1) substrate for various
metabolic pathways [15,16], (2) energy source for intestinal
mucosa [17], (3) mediator for cell signaling [18,19], (4) regulator
for oxidative reactions [20,21], as well as immune responses and
barrier function [22,23].
Considering the known functions of glutamic acid in intestine,
we hypothesized that dietary glutamic acid supplementation may
ameliorate the toxic effects of DON. Therefore, the objective of
the current study was to investigate the effects of glutamic acid
supplementation on the oxidative stress, intestinal barrier loss and
protein inhibition induced by DON in piglets.
Materials and Methods
Preparation of DON-contaminated feed
Fusarium graminearumR6576, producing DON, was kindly pro-
vided by Huazhong Agricultural University (Wuhan, China). The
DON-contaminated feed was prepared according to the previous
reports from our group [13,14].
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Experimental design
This study was conducted according to the guidelines of the
Declaration of Helsinki, and animal protocols were approved by
the animal welfare committee of the Institute of Subtropical
Agriculture, Chinese Academy of Sciences. A total of 28 pigs
(Landrace6Large White) (ZhengHong Co., China) weaned at 28
days of age with a mean body weight (BW) of 12.362.3 kg, were
subjected to four treatments (n = 7 per group): 1) NC group,
weaning pigs received uncontaminated basal diets; 2) DON group,
weaning pigs received 4 mg/kg deoxynivalenol-contaminated
diets; 3) GLU group, weaning pigs received dietary 2% glutamic
acid supplementation; 4) DG group, weaning pigs received 4 mg/
kg deoxynivalenol diets and dietary 2% glutamic aid supplemen-
tation. The concentrations of DON in different groups shown in
Table 1. The basal diets [13] were prepared from corn, soybean
meal, wheat bran, limestone, CaHPO4, salt, and additive premix
to meet or exceed the nutritional requirements of growing pig as
recommended by the NRC (1998) (Table 2). Glutamic acid was
added to the feed and mixed uniformly.
The experiment was arranged as a randomized design.
Experiment animals were allowed free access to water throughout
the experimental period. The trial period lasted for 37 days. At
day 37, piglets were anesthetized with sodium pentobarbital and
killed by jugular puncture. Jejunum and ileum were collected for
intestinal mucosal morphology, diamine oxidase (DAO), maleic
dialdehyde (MDA), total antioxidant capacity (T-AOC), and some
signal proteins analysis. Liver and kidney also were collected to
detect MDA, DAO, hydrogen peroxide (H2O2) and T-AOC.
Serum were prepared on day 15, 30 and 37 for catalase (CAT),
MDA, nitric oxide (NO), H2O2 and amino acids levels determi-
nation. Plasma were prepared on day 15, 30 for D-lactate and
DAO determination.
Antioxidation capacity, D-lactate and amino acids levels
analysis
Spectrophotometric kits was used to analyze several parameters
in samples, including CAT activities, and MDA, NO and H2O2
levels in the serum; T-AOC activity; and MDA and H2O2 levels in
the liver and kidney; as well as T-AOC activity and MDA level in
the jejunum and ileum. The protocol was conducted according to
the manufacturer’s instructions (Nanjing Jiancheng Biotechnology
Institute, China). The reaction system for determining DAO
concentration included 0.1 ml (4 mg) horseradish peroxidase
solution (Sigma), 3 ml 0.2 M, pH 7.2 PBS, 0.1 ml O-dianisidine
methanol solution (500 mg of O-dianisidine) (Sigma), 0.5 ml
sample, and 0.1 ml substrate solution (175 mg of cadaverine
dihydrochloride) (Sigma). Then the processed samples were
incubated in an incubator chamber at 37uC for 30 min and
measured at 436 nm by UV/visible spectrophotometer-UV–2450
(SHIMADZU, Japan) [24]. Plasma D-lactate was determined
Table 1. Deoxynivalenol content in different dietary groups.
Item NC group DON group GLU group DG group
Content
(mg/kg)
1.0960.04 3.9760.05 1.0160.01 4.0460.03
Pigs (7 pigs/group) were fed with uncontaminated basal diet (NC), or basal diet contaminated with deoxynivalenol at dose of 4 mg/kg (DON), or uncontaminated basal
diet supplemented with 2% glutamic acid (GLU), or DON diet supplemented with 2% glutamic acid (DG). Deoxynivalenol content was determined using an assay kit in
accordance with the manufacturer’s instructions (Cusabio, China).
doi:10.1371/journal.pone.0100591.t001
Table 2. Composition and nutrient levels of basal diet (as-fed basis)1.
Ingredients Contents(%) Nutrition levels Contents(%)
Corn 61.25 CP 19.00
Soybean meal 15.79 DE/(MJ/Kg) 14.11
Extruded-soybean 10.00 Calcium 0.80
Imported fish meal 5.00 TP 0.63
Wheat bran 3.00 AP 0.40
Soybean oil 1.74 Lysine 1.15
Premix2 1.00 Methionie+cysteine 0.67
Limestone 0.98 Threonine 0.77
CaHPO4 0.78 Tryptophan 0.22
Salt 0.37
Lysine-HCl 0.09
Total 100.00
1NC= uncontaminated basal diet, DON=basal diet contaminated with deoxynivalenol (4 mg/kg), GLU= uncontaminated basal diet supplemented with 2% glutamic
acid; DG=DON diet supplemented with 2% glutamic acid.
2Providing the following amount of vitamins and minerals per kilogram on an as-fed basis: Zn (ZnO), 50 mg; Cu (CuSO4), 20 mg; Mn (MnO), 55 mg; Fe (FeSO4), 100 mg; I
(KI), 1 mg; Co (CoSO4), 2 mg; Se (Na2SeO3), 0.3 mg; vitamin A, 8,255 IU; vitamin D3, 2,000 IU; vitamin E, 40 IU; vitamin B1, 2 mg; vitamin B2, 4 mg; pantothenic acid,
15 mg; vitamin B6, 10 mg; vitamin B12, 0.05 mg; vitamin PP, 30 mg; folic acid, 2 mg; vitamin K3, 1.5 mg; biotin, 0.2 mg; choline chloride, 800 mg; and vitamin C, 100 mg.
The premix did not contain additional copper, zinc, antibiotics, or probiotics.
CP: Crude Protein; DE: Digestible Energy; TP: Total Phosphorus; AP: Available Phosphorus.
doi:10.1371/journal.pone.0100591.t002
Glutamic Acid and Deoxynivalenol
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using assay kit in accordance with the manufacturer’s instruction
(BioVision Inc., America). The serum was separated with
centrifugation at 3,5006g for 15 min at 4uC and stored at 2
20uC. Concentrations of amino acids in the serum were detected
via LC-MS/MS (HPLC Ultimate3000 and 3200 Q TRAP LC-
MS/MS). Serum amino acids were analyzed with isotope dilution
liquid chromatography-mass spectrometry methods by Beijing
Amino Medical Research CO., LTD, Beijing, China.
Histomorphometry determination
Jejunum and ileum morphology were analyzed using hemotox-
ylin eosin (HE) stain morphology. After dehydration, embedding,
sectioning and staining, villous height, crypt depth, goblet cell and
lymphocyte counts were measured with computer-assisted micros-
copy (Micrometrics TM; Nikon ECLIPSE E200, Japan). For each
intestinal segment, nine villus heights and crypt depths were
measured using Motic Images Advanced 3.2. Measurements were
taken in ten well-oriented villi and ten crpyts from each intestinal
tissue section of each piglet.
Western blot analysis
Western blot analysis was conducted according to a previous
study [25]. Briefly, the equal amounts of proteins obtained from
the ileum and jejunum samples were separated by a reducing
SDS-PAGE electrophoresis. The proteins were transferred onto
PVDF membranes (Millipore, MA, USA) and blocked with 5%
non-fat milk in Tris-Tween buffered saline buffer (20 mM Tris,
pH 7.5,150 mM NaCl, and 0.1% Tween-20) for 3 hr. The
following primary antibodies were incubated overnight at 4uC
with gentle rocking: b-actin (Santa Vruz, 1:400), total 4EBP1 (T-
4EBP1, Cell Signaling, 1:1000), phosphorylated 4EBP1 (Ser 65)
(Cell Signaling, 1:1000), total Akt (T-Akt, Cell Signaling, 1:1000),
phosphorylated Akt (Ser 473) (Cell Signaling, 1:1000), total
mTOR (T-mTOR, Cell Signaling, 1:1000) or phosphorylated
mTOR (Ser 2448) (Cell Signaling, 1:1000). Then, the HRP-
conjugated secondary antibodies were subsequently incubated for
1 hr at room temperature before developing the blots using Alpha
Imager 2200 software (Alpha Innotech Corporation, CA, USA).
We digitally quantified the resultant signals and normalized the
Figure 1. Blood anti-oxidative capacity in each group. A: CAT activity in each group. B: H2O2 concentration in each group. C: MDA
concentration in each group. D: NO concentration in each group. Dietary treatments were NC, an uncontaminated basal diet, DON, the basal
contaminated with 4 mg/kg deoxynivalenol, GLU, uncontaminated basal diet with 2% (g/g) glutamic acid supplementation, and DG, deoxynivalenol-
contaminated (4 mg/kg) basal diet with 2% (g/g) glutamic acid supplementation. Data are presented as means 6 SEM, n= 7, with a–c used to
indicate a statistically significant difference (P,0.05, one way ANOVA method). CAT: catalase (U/ml); H2O2: hydrogen peroxide (mmol/L); MDA:
methane dicarboxylic aldehyde (nmol/ml); NO: nitric oxide (mmol/L).
doi:10.1371/journal.pone.0100591.g001
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Figure 2. Liver and kidney anti-oxidative capacity in each group. A: MDA concentrations of liver and kidney in each group. B: H2O2
concentrations of liver and kidney in each group. C: T-AOC of liver and kidney in each group. Dietary treatments were NC, an uncontaminated basal
diet, DON, the basal contaminated with 4 mg/kg deoxynivalenol, GLU, uncontaminated basal diet with 2% (g/g) glutamic acid supplementation, and
DG, deoxynivalenol-contaminated (4 mg/kg) basal diet with 2% (g/g) glutamic acid supplementation. Data are presented as means6 SEM, n= 7, with
a–b used to indicate a statistically significant difference (P,0.05, one way ANOVA method). MDA: methane dicarboxylic aldehyde (nmol/ml); H2O2:
hydrogen peroxide (mmol/L); T-AOC: total antioxidant capacity (U/mg).
doi:10.1371/journal.pone.0100591.g002
Figure 3. Ileum and jejunum anti-oxidative capacity in each group. A: T-AOC of ileum and jejunum in each group. B: MDA concentrations of
ileum and jejunum in each group. Dietary treatments were NC, an uncontaminated basal diet, DON, the basal contaminated with 4 mg/kg
deoxynivalenol, GLU, uncontaminated basal diet with 2% (g/g) glutamic acid supplementation, and DG, deoxynivalenol-contaminated (4 mg/kg)
basal diet with 2% glutamic acid supplementation. Data are presented as means 6 SEM, n = 7, with a–c used to indicate a statistically significant
difference (P,0.05, one way ANOVA method). MDA: methane dicarboxylic aldehyde (nmol/ml); T-AOC: total antioxidant capacity (U/mg).
doi:10.1371/journal.pone.0100591.g003
Glutamic Acid and Deoxynivalenol
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data to the actin abundance. b-actin was used as an internal
loading control for cytoplasmic protein fractions.
Statistical Analysis
Data are expressed as the mean 6 standard error of the mean
(SEM). All statistical analyses were performed using the SPSS17.0
software (Chicago, IL, USA). Group comparisons were performed
using Tukey multiple range test. Differences were considered
significant at P#0.05.
Results
Anti-oxidative capacity
As shown in Figure 1A, DON significantly (P,0.05) decreased
serum CAT activity compared with controls at day 30 and 37.
This decrease was reversed by glutamic acid supplementation at
day 30 and 37(P,0.05) (Figure 1A). The effect of glutamic acid on
CAT is obvious because a higher CAT activity in the serum was
observed at day 15(P,0.05), 30(P,0.05) and 37(P.0.05), than the
normal group (Figure 1A).
Serum H2O2 levels in DON were higher (P,0.05) than those in
the NC group at day 15, 30 and 37(Figure 1B). Glutamic acid
supplementation significantly reduced (P,0.05) the serum H2O2
concentration at day 30 and 37 (Figure 1B). Interestingly, a higher
level of H2O2 was observed in the piglets fed the DG at day 15
(Figure 1B).
Serum MDA (Figure 1C) and NO (Figure 1D) concentrations
were higher (P,0.05) in piglets fed the DON diet than those fed
the NC diet. These increases were remarkably (P,0.05) alleviated
by glutamic acid supplementation.
Piglets consuming the DON diet had significantly (P,0.05)
increased production of MDA (Figure 2A) and H2O2 (Figure 2B)
in the liver and kidney; while had little effect on the T-AOC
activity in the liver and kidney, compared to those fed the NC diet.
The production of MDA (Figure 2A) and H2O2 (Figure 2B) in the
liver and kidney was significantly lowered with glutamic acid
Figure 4. Plasma DAO activity and D-lactate levels in each group. A: Plasma D-lactate levels in each group on day 15 and day 30. B: Plasma
DAO activity in each group on day 15 and day 30. C: DAO activity of kidney and liver in each group. D: DAO activity of ileum and jejunum in each
group. Dietary treatments were NC, an uncontaminated basal diet, DON, the basal contaminated with 4 mg/kg deoxynivalenol, GLU, uncontaminated
basal diet with 2% (g/g) glutamic acid supplementation, and DG, deoxynivalenol-contaminated (4 mg/kg) basal diet with 2% (g/g) glutamic acid
supplementation. Data are presented as means 6 SEM, n= 7, with a–d used to indicate a statistically significant difference (P,0.05, one way ANOVA
method). DAO: dianine oxidase (U/mg).
doi:10.1371/journal.pone.0100591.g004
Glutamic Acid and Deoxynivalenol
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Figure 5. Image of ileal goblet cells and ileal lymphocytes. A: Ileal goblet cells (6250). B: Ileam lymphocytes (6400). Dietary treatments were
NC, an uncontaminated basal diet, DON, the basal contaminated with 4 mg/kg deoxynivalenol, GLU, uncontaminated basal diet with 2% (g/g)
glutamic acid supplementation, and DG, deoxynivalenol-contaminated (4 mg/kg) basal diet with 2% (g/g) glutamic acid supplementation. n = 7 for
treatments.
doi:10.1371/journal.pone.0100591.g005
Figure 6. Image of jejunum goblet cells and jejunum lymphocytes. A: Jejunum goblet cells (6250). B: Jejunum lymphocytes (6400). Dietary
treatments were NC, an uncontaminated basal diet, DON, the basal contaminated with 4 mg/kg deoxynivalenol, GLU, uncontaminated basal diet
with 2% (g/g) glutamic acid supplementation, and DG, deoxynivalenol-contaminated (4 mg/kg) basal diet with 2% (g/g) glutamic acid
supplementation. n = 7 for treatments.
doi:10.1371/journal.pone.0100591.g006
Glutamic Acid and Deoxynivalenol
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supplementation. Meanwhile, in the liver, the T-AOC activity in
DG group was higher (P,0.05) than those in the DON group
(Figure 2C).
In the ileum, the T-AOC concentration was lower (P,0.05) for
piglets fed the DON-contaminated diets than those fed the NC
diets, while DON had little effect on the jejunum (Figure 3A). In
the ileum and jejunum, MDA content was higher (P,0.05) in the
piglets fed the DON diet than in those fed the other diets
(Figure 3B). The beneficial function of glutamic acid supplemen-
tation was observed again by increased T-AOC activity in DG
group in the jejunum, and decreased MDA levels in DG group in
the ileum and jejunum, compared to the DON groups. (P,0.05)
(Figure 3).
DAO activity, D-lactate levels and Histological Evaluation
DAO activity in serum and tissue, and D-lactate levels in serum
are useful biomarkers for evaluating the integrity of the
gastrointestinal tract [26]. As shown in Figure 4, feeding the
DON diet increased the plasma D-lactate concentration by 13.0%
at day 15, while DON had little effect on plasma D-lactate
concentration at day 30, compared with the piglets feed the NC
diet. However, supplementing the DON-contaminated diet with
2% glutamic acid reduced (P,0.05) plasma D-lactate level by
Table 3. Effect of glutamic acid supplementation on ileal and jejunum morphology in piglets fed a deoxynivalenol-contaminated
diet.
Variable Diets
1
NC DON GLU DG
Goblet cell ileal 22.363.7 17.364.6 16.560.7 18.861.4
jejunum 10.062.5b 17.764.1a 9.2561.55b 11.061.1b
villus height
(VH, mm)
ileal 26368a 171611c 27168a 20264b
jejunum 24567ab 200611b 252612ab 234616a
crypt depth
(CD, mm)
ileal 118614 11164 11467 99.661.9
jejunum 11662ab 156619a 10666b 11068b
lymphocyte ileal 18162c 23266a 17163c 21462b
jejunum 195619c 25666a 203616c 218618b
villus height/crypt depth
(VH/CD)
ileal 2.3260.15a 1.7360.07b 2.4060.09a 1.9560.01ab
jejunum 2.1160.10ab 1.8660.11b 2.2560.06a 2.1360.03ab
n = 7. 1NC= uncontaminated basal diet, DON=basal diet contaminated with deoxynivalenol (4 mg/kg), GLU= uncontaminated basal diet supplemented with 2%
glutamic acid; DG=DON diet supplemented with 2% glutamic acid. Data are presented as means 6 SEM, n = 7, with a–c used to indicate a statistically significant
difference (P,0.05, one way ANOVA method).
doi:10.1371/journal.pone.0100591.t003
Table 4. Effect of dietary supplementation with glutmic acid on serum amino acids levels (mg/ml) in piglets fed a deoxynivalenol-
contaminated diet on day 15.
Item NC DON GLU DG
L-histidine 18.9961.62ab 13.4760.46c 22.9161.08a 16.5561.51bc
L-isoleucine 13.1061.11 13.7361.04 14.0260.58 11.8560.87
L-leucine 25.8562.03a 19.6461.17b 23.3260.74ab 22.5360.45ab
L-methionine 5.0560.59a 0.4160.05c 4.4660.19ab 3.2160.14b
L-threonine 6.7560.69ab 4.6860.46b 8.8460.76a 6.9660.55ab
L-asparagine 7.7560.66a 5.4060.40b 7.8060.31a 6.5260.49ab
L-aspartic acid 0.4960.03 0.4260.02 0.4660.03 0.4260.03
L-glutamic acid 9.2860.52a 7.7460.11b 9.2660.67a 8.9960.42ab
L-ornithine 18.4863.17a 13.0161.53ab 14.0661.32ab 12.0560.68b
L-cystine 1.5060.27a 1.1060.15ab 0.8360.22ab 0.5760.25b
L-carnosine 0.4560.04a 0.3060.04b 0.2660.03b 0.2460.03b
L-proline 46.0263.85a 39.3662.77ab 32.6662.02b 37.7361.56ab
NC= uncontaminated basal diet, DON=basal diet contaminated with deoxynivalenol (4 mg/kg), GLU= uncontaminated basal diet supplemented with 2% glutamic
acid.; DG=DON diet supplemented with 2% glutamic acid. Data are presented as means 6 SEM, n = 7, with a–b used to indicate a statistically significant difference (P,
0.05, one way ANOVA method).
doi:10.1371/journal.pone.0100591.t004
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9.4% and 33.0% at day 15 and 30, respectively. DON significantly
increased the plasma DAO activity by 10.2% (day 15), and 36.1%
(day 30), while DON reduced (P,0.05) the DAO activity in the
liver, kidney, and ileum by 17.1%, 28.9%, and by 32.6% on day
37, respectively, compared with the control. However, supple-
menting the DON-contaminated diet with 2% glutamic acid
reduced (P,0.05) plasma DAO activity by 12.7% and 20.0%, at
day 15 and 30, respectively, while increased DAO activity by
28.8%, 27.5%, and 29.5% 8 in the liver, kidney, and ileum, at day
37, respectively.
As shown in Figures 5 and 6, Tables 3, there was no histological
damage in the piglets fed the NC diet. However, compared with
the NC diet, feeding the DON diet reduced (P,0.05) villus height
in the ileum and jejunum, and increased lymphocytes (P,0.05) in
the ileum and jejunum, and goblet cells (P,0.05) in the jejunum.
Feeding the DG diet increased (P,0.05) villus height in the ileum
and jejunum, and reduced (P,0.05) lymphocytes, goblet cells, and
crypt depth in the jejunum.
Intestinal signaling and amino acid profile
Feeding the DON diet generally reduced amino acid contents in
the small intestine (Tables 4, 5, and 6), and these effects were
significant (P,0.05) for L-isoleucine, L-methionine, L-threonine,
L-asparagine, L-glutamic acid, and L-proline. However, feeding
the DG diet increased the intestinal contents of these amino acids
(P,0.05).
Although reports have suggested that many mycotoxins,
including DON, may influence the MAPKs and/or PI3K
Table 5. Effect of dietary supplementation with glutmic acid on serum amino acids levels (mg/ml) in piglets fed a deoxynivalenol-
contaminated diet on day 30.
Item NC DON GLU DG
L-histidine 29.4161.57 23.0261.06 22.1961.59 22.0461.03
L-isoleucine 17.2261.16a 12.6460.73b 16.6360.86a 14.3360.42ab
L-leucine 30.6463.05a 23.6161.29b 30.1860.91a 26.4161.17ab
L-methionine 0.7260.07 0.5160.03 0.8460.09 0.7060.06
L-threonine 12.9960.71 10.5060.97 11.0460.96 11.7960.70
L-asparagine 10.2061.37 9.0560.93 9.7060.42 8.4560.47
L-aspartic acid 0.7160.05 0.6160.03 0.6460.02 0.6660.07
L-glutamic acid 10.8260.88a 8.0060.34b 10.8460.27a 9.6360.54ab
L-Ornithine 21.3764.23ab 13.0161.06b 28.2361.85a 23.9862.70a
L-cystine 1.5460.35a 0.3960.03b 1.3960.48a 0.4460.05b
L-carnosine 0.5360.05 0.4060.03 0.4060.04 0.4060.02
L-proline 35.6163.18 36.3960.50 45.5161.56 36.2860.63
NC= uncontaminated basal diet, DON=basal diet contaminated with deoxynivalenol (4 mg/kg), GLU= uncontaminated basal diet supplemented with 2% glutamic
acid; DG =DON diet supplemented with 2% glutamic acid. Data are presented as means 6 SEM, n = 7, with a–b used to indicate a statistically significant difference (P,
0.05, one way ANOVA method).
doi:10.1371/journal.pone.0100591.t005
Table 6. Effect of dietary supplementation with glutmic acid on serum amino acids levels in piglets fed deoxynivalenol-
contaminated feed on day 37.
Item NC DON GLU DG
L-histidine 34.9961.68a 23.2762.65b 31.1062.91ab 34.6261.63a
L-isoleucine 11.9660.96 8.9160.86 12.3260.18 10.8360.32
L-leucine 27.5962.01 26.6062.22 28.0361.08 24.2861.69
L-methionine 0.3660.01bc 0.2660.02c 0.5660.04a 0.3860.02b
L-threonine 9.5460.54ab 6.4860.63c 11.1860.49a 7.9660.46bc
L-asparagine 8.3360.56a 4.7060.26b 8.1360.57a 8.0560.53a
L-aspartic acid 0.5860.06 0.5460.07 0.5460.05 0.4760.04
L-glutamic acid 10.2460.51a 3.4560.29c 9.2960.19ab 7.6860.52b
L-Ornithine 25.7763.43 18.9361.81 23.6364.35 17.1161.22
L-cystine 1.0760.26 1.2760.24 0.9660.17 0.9260.09
L-carnosine 0.4560.03a 0.3260.04b 0.6360.06ab 0.5260.06ab
L-proline 35.1062.01a 25.8960.92c 31.2961.06ab 30.1661.00b
NC= uncontaminated basal diet, DON=basal diet contaminated with deoxynivalenol (4 mg/kg), GLU= uncontaminated basal diet supplemented with 2% glutamic
acid; DG=DON diet supplemented with 2% glutamic acid. Data are presented as means 6 SEM, n = 7, with a–c used to indicate a statistically significant difference (P,
0.05, one way ANOVA method).
doi:10.1371/journal.pone.0100591.t006
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signaling pathways [27], there is no evidence so far to show
whether DON has an influence on the Akt/mammalian target of
rapamycin (mTOR)/eukaryotic initiation factor 4e-binding pro-
tein 1(4EBP1) pathway. Previous studies reported that DON
inhibits protein synthesis via binding to the 60S subunit of
eukaryotic ribosomes [28] or activating the mitogen-activated
protein (MAPK) signaling pathway [29,30]. Therefore, in the
present study we investigated the protein expression levels of
4EBP1, p-4EBP1, Akt, p-Akt, mTOR and p-mTOR in the ileum
and jejunum so as to elucidate the detailed mechanisms by which
DON induces cell death. As shown in Figure 7 and 8, feeding the
DON diet reduced (P,0.05) phosphorylation levels and total
protein abundance of Akt in the ileum (Figure 7) and jejunum
(Figure 8), and phosphorylation levels of 4EBP1 in the jejunum
(Figure 8), compared with feeding the NC diet. Glutamic acid
supplementation increased (P,0.05) the protein phosphorylation
of 4EBP1 by 21.3% in the ileum (Figure 7) and 57.4% in the
jejunum (Figure 8), the protein phosphorylation of Akt by 86.8%
(P,0.05) in the ileum (Figure 7) and 203.2% (P,0.05) in the
jejunum (Figure 8), the phosphorylation of mTOR by 61.5% in
the ileum (Figure 7) and 33.2% in the jejunum (Figure 8),
compared with the DON diet.
Discussion
CAT activity, T-AOC, H2O2, NO and MDA levels are widely
accepted markers for oxidative stress [22,31–34]. The present
study showed that consuming DON-contaminated diets causes
obvious oxidative stress to piglets from the change of analyzed
indicators. Indeed, DON induced oxidative stress is widely
observed in chickens [35], mice [36], pigs [13], rats [37], fish
[38], and even cell lines isolated from human [39]. Intriguingly,
our results demonstrated that supplementing glutamic acid to
DON-contaminated piglet diet alleviates the oxidative stress
caused by DON from the change of CAT, T-AOC, MDA and
H2O2. It is well established that glutamate is involved in the
Figure 7. Activation of mTOR in ileum. (Up) Representative western blots of total 4EBP1(T-4EBP1), phosphorylated 4EBP1 (Ser65) (P-4EBP1), total
Akt (T-Akt), phosphorylated Akt (Ser473) (P-Akt), total mTOR (T- mTOR), phosphorylated mTOR (Ser2448) (P- mTOR) in ileal of piglets fed the various
dietary treatments. b-actin was the loading control. (Down) Quantification by image analysis of 4EBP1, Akt and mTOR phosphorylation. Dietary
treatments were NC, an uncontaminated basal diet, DON, the basal contaminated with 4 mg/kg deoxynivalenol, GLU, uncontaminated basal diet
with 2% (g/g) glutamic acid supplementation, and DG, deoxynivalenol-contaminated (4 mg/kg) basal diet with 2% (g/g) glutamic acid
supplementation. n = 7 for treatments.
doi:10.1371/journal.pone.0100591.g007
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oxidative response in body because L-glutamate is a precursor for
glutathione, which is involved in the enterocyte redox state and in
the detoxification process in enterocytes [40]. Further data about
the serum GSH levels are needed to validate this explanation.
Reduced DAO activity in the intestine and kidney, and
increased D-lactate level in serum are shown to correlate with
the extent of histologic injury [41,42]. Thus, in addition to
microscopic lesions in intestine, the D-lactate concentration in
serum, and DAO activity in serum and tissue were also detected to
assess the effects of DON exposure on intestinal barrier function.
The increased blood D-lactate levels, and reduced intestinal and
kidney DAO activity suggest that the intestinal barrier integrity is
severely compromised by DON intake. This reasoning also is
demonstrated by the microscopic observation in the jejunum and
ileum. The reasonable contributors come from the effect DON on
wall morphology, tight junction, inflammation, oxidative stress,
epithelial proliferation [35,43,44]. Interestingly, DON affects the
intestinal epithelial barrier from both the apical (luminal) and
basolateral (serosal) side [45]. Compellingly, supplementing
glutamic acid to DON-contaminated diets promotes the intestinal
recovery in piglets. In fact, increasing investigations in vivo and
in vitro have demonstrated that glutamic acids exerts significant
beneficial effects on intestinal barrier function [46,47]. This
intestinal barrier dysfunction might be associated with intestinal
metabolism because the concentration of amino acid has a
downward trend in DON group, while seven amino acids in DG
group are increased, compared to DON group. The possible
explanation is that glutamic acid, in addition to being used for
protein synthesis within the intestinal mucosa, can also be used by
enterocytes to produce other amino acids [48,49].
The mTOR is a 289 kDa serine/threonine kinase, which plays
a key role in regulating cell growth and proliferation [50].
Moreover, 4EBP1 is phosphorylated by mTOR to regulate
translation initiation [51], whereas Akt contributes to mTOR
activation [52]. Results showed that these proteins are significantly
down-regulated after exposure to DON, indicating DON inhibits
protein synthesis, consequently leading to decreased cell prolifer-
ation [53,54]. Previous report showed several mycotoxins,
particularly DON, causes the cell cycle arrest in the Gap2/
Metaphase (G2/M) phase [55–57]. The G2/M arrest in intestinal
epithelium cells caused by DON is associated with its inhibition on
Akt/mTOR pathway because the inhibition of Akt/mTOR
Figure 8. Activation of mTOR in jejunum. (Up) Representative western blots of total 4EBP1(T-4EBP1), phosphorylated 4EBP1 (Ser65) (P-4EBP1),
total Akt (T-Akt), phosphorylated Akt (Ser473) (P-Akt), total mTOR (T- mTOR), phosphorylated mTOR (Ser2448) (P- mTOR) in jejunum of piglets fed the
various dietary treatments. b-actin was the loading control. (Down) Quantification by image analysis of 4EBP1, Akt and mTOR phosphorylation.
Dietary treatments were NC, an uncontaminated basal diet, DON, the basal contaminated with 4 mg/kg deoxynivalenol, GLU, uncontaminated basal
diet with 2% (g/g) glutamic acid supplementation, and DG, deoxynivalenol-contaminated (4 mg/kg) basal diet with 2% (g/g) glutamic acid
supplementation. n = 7 for treatments.
doi:10.1371/journal.pone.0100591.g008
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induces G2/M arrest in cells [58]. The levels of these proteins are
up-regulated with dietary glutamic acid supplementation (DG
group). This indicated that glutamic acid contributes to protein
synthesis by regulating cell cycles. Indeed, previous studies have
shown that glutamic acid appears to be involved in cellular
signaling and growth regulation [15,59,60].
Taken together, our findings demonstrated that DON induces
oxidative stress, and increases intestinal permeability, as well as
inhibits protein synthesis and cell proliferation in weaned piglets.
Glutamic acid supplementation decreases the oxidative stress and
the intestinal permeability, and reverses Akt/mTOR/4EBP1
signaling caused by DON, indicating glutamic acid is a useful
nutritional regulator for DON damage.
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